Letters to the Editor
Biological materials used in reconstruction of the ear From Mr Charles A Akle London WI Dear Sir, I read Mr Ironside's article with much interest (September 1982 Journal, p 691) . I would like to draw attention to another possible material for tympanic membrane replacement which is cheap, readily available, and poorly immunogenic -namely, the human amniotic membrane.
We have recently demonstrated that the human amniotic epithelium does not express on its surface either the major histocompatibility antigens or beta-2-microglobulin (Adinolfi et al. 1982) . In addition, it does not evoke a classical acute rejection phenomenon when implanted subcutaneously into human volunteers (Akle et al. 1981) .
It has been used as an implant in many patients over the years, both in its natural and in modified states, without ill effect. It has been used more recently to replace nasal mucosa in patients with hereditary haemorrhagic telangiectasia, with apparent success (Laurian et al. 1979) . Currently, I and co-workers at the Paediatric Research Unit, Guy's Hospital, are using implants of the epithelium to try and replace the deficient enzyme in children with Hunter and Hurler syndromes, and the early results are encouraging.
I would be grateful to hear from anyone who has used the amnion for tympanic membrane replacement or who would be prepared to try it. For some years now, medical students from two London teaching hospitals have received regular instruction here on the problems of long-term disablement. In addition, monthly clinical meetings are held in the lunch hour, and one-day seminars at about the same interv.als.
We, like Dr Frank (September 1982 Journal, p 752), regard education in the problems of disablement following illness or injury as of great importance. It is important for all of us to remember that many conditions are still 'incurable', but none is 'untreatable', Yours sincerely Nevertheless, it was a little disappointing that Mr McMaster should write: 'School screening is best carried out as part of a routine medical examination by an informed school doctor who refers patients to a specialized scoliosis clinic at his own discretion'. I am sure your readers will know that this is not generally accepted and that the Royal College of General Practitioners' recent report 'Healthier Children Thinking Prevention' (1982) specifically recommends that these checks should be done within primary care and gives detailed reasons why preventive medical care of children should take place within the primary health care team.
Nor is it desirable for clinic doctors to refer direct to specialists' or ultra-specialists, because this tends to lead to lack of communication, and many of us in general practice like to make all such referrals ourselves and to keep in close touch with families on a long-term basis. should be of considerable value to the general practitioner in whose office many of the children with scoliosis appear prior to referral. The necessity for appropriate referral to a paediatric orthopaedist cannot be over-stressed. Unfortunately, despite early school screening and school nurse evaluations, many of these children with progressive curves arrive far too late in the orthopaedist's office.
The publication of this editorial was timely, as we all need to be reminded of the management of scoliosis that may be instituted in order further to decrease the incidence of the crippling deformity of the untreated scoliosis patient. Sincerely JON G MCLENNAN 8 October 1982 Vancomycin and chronic hypotension However, the literature does not appear to support the statement that vancomycin induces chronic hypotension. Indeed, the paper cited by Dr Bleddyn Davies .does not refer to chronic hypotension but describes brief episodes of hypotension following bolus intravenous injections of vancomycin (Newfield & Roizen 1979) .
The authors report that hypotensive episodes do not occur if the drug is administered over a 30 minute period according to the manufacturer's recommendation. Intact and isolated animal experiments are reported to show myocardial depression (Cohen et al. 1970 ) but I am not aware of any other reports in the literature of such reactions occurring in humans.
During an ongoing, prospective study of vancomycin toxicity, I have not been aware of clinically-significant acute or chronic hypotension in 25 patients receiving up to 70 g vancomycin. Although the presence of hypotension has not been specifically sought, it seems likely that significant myocardial depression would have declared itself. Yours faithfully JOHN MELLOR 14 October 1982 
